Marc Beer is the Chief Executive Officer, Chairman, and Co-founder of the startup known as Renovia Inc. Marc has over 25 years of professional experience in the fields of pharmaceuticals, biotech, health diagnostics, and devices. Marc completed his graduation in business in 1987 from the Miami University. Over the years, he developed excellent business and management skills. He worked with many startups and took them to success as well as working as an advisor.
In 2000, Marc founded ViaCell as its CEO. This company focused on biotechnology and used it to develop blood stem cells. Leading the company for 7 years, Marc took ViaCell from zero to a full-fledged commercial organization with the employee tally going beyond 300. In 2007, ViaCell was bought by PerkinElmer.
Marc has also served in many other organizations in key positions. He has been a member of the board of directors of a Pharmaceutical company, known as Erytech Pharma. Other biotechnological companies where he has worked include Good Start Genetics Inc., Genzyme, Abbot Laboratories and Minerva Neurosciences Inc.
Marc Beer and Renovia
His most recent venture is Renovia, a biotech company that focuses on women’s health, started in 2016. Recently, Marc has successfully managed to receive funding in a series B round which amounts to $32 million and $10 million dollars through venture debt. He is aiming to develop products that could help diagnose a pelvic floor disorder. According to estimates, as much as 250 million women might be affected by it which clearly show how much of an impact this product could make.
As of April 2018, Renovia got its first product approved which is named as Leva. The funding received by Renovia would help in the development of four more products, while Marc also aims to improve Leva and introduce a newer version of the product. While announcing the funding, Marc appreciated the investors for their financial support and showed his intentions to focus on using technology to solve health-related problems. Learn more: https://www.slideshare.net/MarcBeer
Renovia intends to develop products that would treat pelvic floor disorders by making pelvic muscles stronger. It would used approved and tested devices along with data management through apps or other software that could be used by the patients. This would help patients take control of their pelvic health.
Marc Beer and Renovia are using technology and innovation to solve health problems. While a large number of women are facing the pelvic floor disorder, a biotechnological startup like this, which makes full use of modern science, could be a lifesaver for so many women out there. Future prospects also look great as Renovia is receiving a good amount of funding and has 4 more products in development. Marc’s vast experience in the field of pharma and biotech could be key here and can make Renovia solve women’s health issues.